1. Radiation therapy for urological cancers
   S Ahmad et al, 2016, Journal of Clinical Urology CrossRef
2. Strontium-89 plus zoledronic acid versus zoledronic acid for patients with painful bone metastatic breast cancer
   Kimito Yamada et al, 2022, Journal of Bone and Mineral Metabolism CrossRef
3. Research Progression in the Mechanism of Bone Metastasis and Bone-Targeted Drugs in Prostate Cancer
   Sajjad Ahmad, 2024, annals of urologic oncology CrossRef
4. Current state of theranostics in metastatic castrate‐resistant prostate cancer
   Udit Nindra et al, 2024, Journal of Medical Imaging and Radiation Oncology CrossRef
5. A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with 68Ga, 44Sc, 177Lu and 161Tb
   Zeynep Talip et al, 2020, Molecules CrossRef
6. Trace Elements Alleviate Pain in Mice and Humans
   B.I. Tamba et al, 2017, Nutritional Modulators of Pain in the Aging Population CrossRef
7. Strontium-89 chloride delivery for painful bone metastases in patients with a history of prior irradiation
   Anneyuko I. Saito et al, 2023, Irish Journal of Medical Science (1971 -) CrossRef
8. Exploiting bone niches: progression of disseminated tumor cells to metastasis
   Aaron M. Muscarella et al, 2021, Journal of Clinical Investigation CrossRef
9. The Role of Radiopharmaceuticals in the Bone Metastases Therapy
   Hümeyra BATTAL et al, 2023, Fabad Journal of Pharmaceutical Sciences CrossRef
10. Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response
    Daria Klusa et al, 2021, Frontiers in Oncology CrossRef
11. Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer
    Robert B. Den et al, 2019, American Journal of Clinical Oncology CrossRef
12. A comparative evaluation of calix[4]arene-1,3-crown-6 as a ligand for selected divalent cations of radiopharmaceutical interest
    David Bauer et al, 2019, RSC Advances CrossRef